Avoid common mistakes on your manuscript.
Correction to: Molecular and Cellular Biochemistry (2016) 415:145–155 https://doi.org/10.1007/s11010-016-2686-1
In the original publication of the article, Fig. 1C was published incorrectly. The correct version of Fig. 1 is provided in this correction.
Physalin A (PA) induced growth inhibition and reactive oxygen species (ROS) generation in human non-small-cell lung cancer A549 cell. A Chemical structure of PA. B A549 cells were treated with various doses (0, 12, 16, 21.3, 28.4, and 38 µM) of PA for 3, 6, 12, and 24 h. Cell growth inhibition rate (%) was measured using the MTT assay. Data are shown as mean ± standard deviation (SD) from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus controls (0 µM PA) at the same time point. C A549 cells were cultured with 28.4 µM PA for 0, 3, 6, 12, and 24 h in the absence or presence of 3 mM N-acetylcysteine (NAC), the ROS scavenger. The generation of ROS was measured by flow cytometry using the ROS-detecting fluorescent dye DCF-DA. Data are shown as mean ± SD from three independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 versus control group (28.4 µM PA for 0 h); ##P < 0.01 versus A549 cells treated with 28.4 µM PA for 24 h
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kang, N., Jian, Jf., Cao, Sj. et al. Correction to: Physalin A induces G2/M phase cell cycle arrest in human non-small cell lung cancer cells: involvement of the p38 MAPK/ROS pathway. Mol Cell Biochem 477, 331–332 (2022). https://doi.org/10.1007/s11010-021-04318-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-021-04318-8